Michalis Gounis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michalis Gounis has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Cassie J. Clarke
Cancer Research UK Scotland Institute, Glasgow, G61 1BD, United Kingdom
2 shared publications - Colin Nixon
Cancer Research UK Scotland Institute, Glasgow, United Kingdom
2 shared publications - David Novo
Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK
2 shared publications - David Sumpton
CRUK Scotland Institute
2 shared publications - Emmanuel Dornier
CRUK Beatson Institute for Cancer Research, Garscube Estate, Glasgow, G61 1BD, UK
2 shared publications - Iain Rj Macpherson
School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
2 shared publications
Latest Publications
- Open Access
- 23 July 2025
- Published by Springer Nature in EMBO Reports
- Vol. 26 (17) , 4248-4282
Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes
Understanding mechanisms that facilitate early events in metastatic seeding is key to developing therapeutic approaches to reduce metastasis. Here we identify uracil as a metastasis-associated metabolite in genetically engineered mouse models of cancer and in patients with metastatic breast cancer. Uracil is generated by the enzyme uridine phosphorylase-1 (UPP1), and we find that neutrophils are a significant source of UPP1 in metastatic cancer. Mammary tumours increase expression of adhesion molecules on the neutrophil surface, in a UPP1-dependent manner, leading to decreased neutrophil motility in the pre-metastatic lung. UPP1-expressing neutrophils suppress T-cell proliferation, and the UPP1 product uracil increases fibronectin deposition in the extracellular microenvironment. Knockout or inhibition of UPP1 in mice with mammary tumours increases T-cell numbers and reduces fibronectin content in the lung, and decreases the proportion of mice that develop lung metastasis. These data indicate that UPP1 influences neutrophil behaviour and extracellular matrix deposition in the lung, and suggest that circulating uracil could be a marker of metastasis, and that pharmacological inhibition of UPP1 could be a strategy to reduce recurrence.
- 23 July 2025
- Published by Springer Nature in EMBO Reports
- Vol. 26 (17) , 4248-4282
Open AccessUridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes
Understanding mechanisms that facilitate early events in metastatic seeding is key to developing therapeutic approaches to reduce metastasis. Here we identify uracil as a metastasis-associated metabolite in genetically engineered mouse models of cancer and in patients with metastatic breast cancer. Uracil is generated by the enzyme uridine phosphorylase-1 (UPP1), and we find that neutrophils are a significant source of UPP1 in metastatic cancer. Mammary tumours increase expression of adhesion molecules on the neutrophil surface, in a UPP1-dependent manner, leading to decreased neutrophil motility in the pre-metastatic lung. UPP1-expressing neutrophils suppress T-cell proliferation, and the UPP1 product uracil increases fibronectin deposition in the extracellular microenvironment. Knockout or inhibition of UPP1 in mice with mammary tumours increases T-cell numbers and reduces fibronectin content in the lung, and decreases the proportion of mice that develop lung metastasis. These data indicate that UPP1 influences neutrophil behaviour and extracellular matrix deposition in the lung, and suggest that circulating uracil could be a marker of metastasis, and that pharmacological inhibition of UPP1 could be a strategy to reduce recurrence.
- Open Access
- 9 June 2025
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 224 (8)
Metabolic adaptations of micrometastases alter EV production to generate invasive microenvironments
Altered cellular metabolism has been associated with the acquisition of invasive phenotypes during metastasis. To study this, we combined a genetically engineered mouse model of mammary carcinoma with syngeneic transplantation and primary tumor resection to generate isogenic cells from primary tumors and their corresponding lung micrometastases. Metabolic analyses indicated that micrometastatic cells increase proline production at the expense of glutathione synthesis, leading to a reduction in total glutathione levels. Micrometastatic cells also have altered sphingomyelin metabolism, leading to increased intracellular levels of specific ceramides. The combination of these metabolic adaptations alters extracellular vesicle (EV) production to render the microenvironment more permissive for invasion. Indeed, micrometastatic cells shut down Rab27-dependent production of EVs and, instead, switch on neutral sphingomyelinase-2 (nSM2)-dependent EV release. EVs released in an nSM2-dependent manner from micrometastatic cells, in turn, influence the ability of fibroblasts to deposit extracellular matrix, which promotes cancer cell invasiveness. These data provide evidence that metabolic rewiring drives invasive processes in metastasis by influencing EV release.
- 9 June 2025
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 224 (8)
Open AccessMetabolic adaptations of micrometastases alter EV production to generate invasive microenvironments
Altered cellular metabolism has been associated with the acquisition of invasive phenotypes during metastasis. To study this, we combined a genetically engineered mouse model of mammary carcinoma with syngeneic transplantation and primary tumor resection to generate isogenic cells from primary tumors and their corresponding lung micrometastases. Metabolic analyses indicated that micrometastatic cells increase proline production at the expense of glutathione synthesis, leading to a reduction in total glutathione levels. Micrometastatic cells also have altered sphingomyelin metabolism, leading to increased intracellular levels of specific ceramides. The combination of these metabolic adaptations alters extracellular vesicle (EV) production to render the microenvironment more permissive for invasion. Indeed, micrometastatic cells shut down Rab27-dependent production of EVs and, instead, switch on neutral sphingomyelinase-2 (nSM2)-dependent EV release. EVs released in an nSM2-dependent manner from micrometastatic cells, in turn, influence the ability of fibroblasts to deposit extracellular matrix, which promotes cancer cell invasiveness. These data provide evidence that metabolic rewiring drives invasive processes in metastasis by influencing EV release.
- Open Access
- 26 May 2025
- Published by Springer Nature in Nature Cell Biology
- Vol. 27 (6) , 1021-1034
Dynamic regulation of integrin β1 phosphorylation supports invasion of breast cancer cells
Integrins provide an essential bridge between cancer cells and the extracellular matrix, playing a central role in every stage of disease progression. Despite the recognized importance of integrin phosphorylation in several biological processes, the regulatory mechanisms and their relevance remained elusive. Here we engineer a fluorescence resonance energy transfer biosensor for integrin β1 phosphorylation, screening 96 protein tyrosine phosphatases and identifying Shp2 and PTP-PEST as negative regulators to address this gap. Mutation of the integrin NPxY(783/795) sites revealed the importance of integrin phosphorylation for efficient cancer cell invasion, further supported by inhibition of the identified integrin phosphorylation regulators Shp2 and Src kinase. Using proteomics approaches, we uncovered Cofilin as a component of the phosphorylated integrin-Dok1 complex and linked this axis to effective invadopodia formation, a process supporting breast cancer invasion. These data further implicate dynamic modulation of integrin β1 phosphorylation at NPxY sites at different stages of metastatic dissemination.
- 26 May 2025
- Published by Springer Nature in Nature Cell Biology
- Vol. 27 (6) , 1021-1034
Open AccessDynamic regulation of integrin β1 phosphorylation supports invasion of breast cancer cells
Integrins provide an essential bridge between cancer cells and the extracellular matrix, playing a central role in every stage of disease progression. Despite the recognized importance of integrin phosphorylation in several biological processes, the regulatory mechanisms and their relevance remained elusive. Here we engineer a fluorescence resonance energy transfer biosensor for integrin β1 phosphorylation, screening 96 protein tyrosine phosphatases and identifying Shp2 and PTP-PEST as negative regulators to address this gap. Mutation of the integrin NPxY(783/795) sites revealed the importance of integrin phosphorylation for efficient cancer cell invasion, further supported by inhibition of the identified integrin phosphorylation regulators Shp2 and Src kinase. Using proteomics approaches, we uncovered Cofilin as a component of the phosphorylated integrin-Dok1 complex and linked this axis to effective invadopodia formation, a process supporting breast cancer invasion. These data further implicate dynamic modulation of integrin β1 phosphorylation at NPxY sites at different stages of metastatic dissemination.
- Open Access
- 23 October 2019
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (12) , 1249
Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 23 October 2019
- Published by Springer Nature in Nature Chemical Biology
- Vol. 15 (12) , 1249
Open AccessAuthor Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG
An amendment to this paper has been published and can be accessed via a link at the top of the paper.